MedPath

Pharmaceutical Companies

Mirum Pharmaceuticals logo

Mirum Pharmaceuticals

🇺🇸United States
Ownership
Public
Established
2018-01-01
Employees
264
Market Cap
$2.1B
Website
http://www.mirumpharma.com
Mirum Pharmaceuticals, Inc. is a biopharmaceutical company. The firm focuses on the development and commercialization of a late-stage pipeline of novel therapies for debilitating liver diseases. Its products include Maralixibat and...
Almirall, LLC logo

Almirall, LLC

🇺🇸United States
Ownership
-
Established
-
Employees
-
Market Cap
$2B
Website
-
Vera Therapeutics logo

Vera Therapeutics

🇺🇸United States
Ownership
Public
Established
2016-01-01
Employees
51
Market Cap
$2B
Website
http://www.veratx.com
Vera Therapeutics, Inc. is a clinical stage biotechnical company which engages in the development and commercialization of transformative treatments for immunological diseases. The company was founded by Marshall Fordyce in May 2016 and is...

GRANULES INDIA

🇮🇳India
Ownership
-
Established
-
Employees
-
Market Cap
$2B
Website
-
Harmony Biosciences, LLC logo

Harmony Biosciences, LLC

🇺🇸United States
Ownership
-
Established
-
Employees
-
Market Cap
$2B
Website
-
Galapagos logo

Galapagos

🇧🇪Belgium
Ownership
Public
Established
1999-01-01
Employees
1.1K
Market Cap
$1.9B
Website
http://www.glpg.com
Galapagos NV is a biotechnology company, which engages in the identification and development of small molecule and antibody therapies. Its clinical pipeline includes filgotinib, GLP3667, Toledo program, and idiopathic pulmonary fibrosis....
Ownership
-
Established
-
Employees
297
Market Cap
$1.9B
Website
-
Kiniksa Pharmaceuticals International Plc is a commercial-stage biopharmaceutical company. It engages in discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with...

Zai Lab

🇨🇳China
Ownership
-
Established
-
Employees
2.1K
Market Cap
$1.9B
Website
-
Zai Lab Ltd. is a biopharmaceutical company, which engages in the developing and commercializing therapies that address medical conditions with unmet needs in oncology, autoimmune disorders, infectious diseases, and neuroscience. Its...
Supernus Pharmaceuticals logo

Supernus Pharmaceuticals

🇺🇸United States
Ownership
Public
Established
2005-01-01
Employees
652
Market Cap
$1.9B
Website
http://www.supernus.com
Supernus Pharmaceuticals, Inc. engages in the development and commercialization of products for the treatment of central nervous system diseases. It offers Trokendi XR, Oxtellar XR, APOKYN, XADAGO, and MYOBLOC products. The company was...
Ownership
-
Established
-
Employees
-
Market Cap
$1.9B
Website
-
© Copyright 2025. All Rights Reserved by MedPath